Red yeast rice contains multiple bioactive substances, as it is made by fermenting process with a type of yeast known as Monascus purpureus. Red yeast rice contains a compound known as monacolin K that has been proven to lower cholesterol levels, and is often utilized as a medical product. Moreover, traditional medicine powder form of red yeast rice is also used as a dietary supplement, which in turn increases demand for red yeast rice market. The gradually increasing health issues such as blood pressure, indigestion and cholesterol, among young adults, due to change in lifestyle and eating habits is leading to increasing consumption of red yeast rice-based oral supplements.
Integrative Medicinal Properties Supports Market Growth
Demand for red yeast rice is primarily driven across the world due to its wide range of applications as health products and food additives. The number of increasing chronic diseases due to change in eating habits of consumers is boosting market growth. Therapeutic applications of red yeast rice involves lowering of cholesterol drug lovastatin in human body. In addition, red yeast rice is also used as food additives in regional markets such as Asian countries and U.S. as it helps in treating digestion related health issues.
Further, the red yeast rice which is used as dietary supplements helps to lower body cholesterol levels in human beings. However, the fungi used in the production of end-product has a negative effect. Red yeast rice may lead to the production ‘citrinin’ toxin in human body, which causes kidney related health diseases. This factor is challenging the growth of red yeast rice market on a global level.
The red yeast rice market is segmented on the basis of type, application, and sales channel.
On the basis of type, the global Red Yeast Rice market is segmented as-
On the basis of application, the global red yeast rice market is segmented as-
On the basis of Sales Channel, the global red yeast rice market is segmented as-
Some of the prominent players identified in the red yeast rice Market includes: Qingdao BNP Co. Ltd., Zhejiang Sanhe Bio-tech Co Ltd., Now Health Group Inc., Zenith Food Solutions Private Limited., Solgar Inc., Weider Global Nutrition, Wakunaga Pharmaceutical Co. Ltd., BioScience Nutrition, Nutraceutical Corporation and many others. Some of the local regional level players are also showing keen interest in red yeast rice market as it has wide application in food and pharmaceutical industry.
There are certain side-effects of statin-based red yeast rice. Initially, companies started offering statin based red yeast rice for statin therapy, which in turn left patients at a high risk of cardiac arrests. The sole reason for this effect was the toxicity of statin based red yeast rice for therapy. Today, companies are offering statin-free red yeast rice with no side effects. Companies use laboratory equipment to test therapeutic red yeast rice for the presence of alanine aminotransferase and aspartate aminotransferase, which cause liver damage. After confirming the absence of these enzymes, the red yeast rice is marketed for therapeutic applications. Marketing statin-free red yeast rice for therapeutic applications is one of the key opportunities in the global market.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
Complete the form below and we'll get back to you shortly.